A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

December 2, 2022

Primary Completion Date

April 14, 2025

Study Completion Date

April 14, 2025

Conditions
Healthy ParticipantsAlzheimer's Disease Dementia
Interventions
DRUG

Emraclidine

Oral tablets

DRUG

Placebo

Oral tablets

Trial Locations (11)

10314

Staten Island, New York, Staten Island

30030

Decatur, Georgia, Decatur

33014

Hialeah, Florida, Hialeah

44720

North Canton, Ohio, North Canton

48334

Farmington Hills, Michigan, Farmington Hills

66212

Overland Park, Kansas, Overland Park

90630

Cypress, California, Cypress

92103

San Diego, California, San Diego

96817

Honolulu, Hawaii, Honolulu

08053

Marlton, New Jersey, Marlton

08540

Princeton, New Jersey, Princeton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY